External audits of sequencing pipelines

Introduction

External audits of sequencing pipelines are an important component of biotechnology governance, laboratory accreditation, data protection and scientific accountability. Sequencing pipelines are structured technological processes used to analyse biological information, particularly DNA, RNA and other genetic materials. These pipelines involve several stages, including sample preparation, sequencing, data processing, quality control, genome alignment, variant identification, interpretation and reporting.

External audits involve an independent examination of these processes by qualified auditors, regulatory authorities or accredited third-party organisations. Their primary purpose is to ensure that sequencing laboratories follow scientifically reliable procedures, maintain data integrity, protect sensitive genetic information and comply with applicable legal and ethical requirements.

With the expansion of genomic medicine, personalised healthcare, genetic testing and biotechnology research, sequencing pipelines increasingly influence medical diagnosis, scientific discoveries and public health decisions. Errors in sequencing data or analytical procedures may produce inaccurate results and affect patient treatment. Therefore, independent auditing helps establish confidence in genomic technologies and promotes responsible biotechnology practices.

Meaning and scope of external audits of sequencing pipelines

An external audit is an independent assessment of the technical, administrative and regulatory processes involved in genomic sequencing.

Unlike internal audits conducted by laboratory employees, external audits are performed by independent experts or authorised assessment bodies. These auditors examine whether the sequencing pipeline operates according to established scientific standards, regulatory requirements and documented procedures.

The scope of external audits generally includes:

Sample management: Examination of sample collection, identification, storage and transportation procedures.

Sequencing accuracy: Assessment of sequencing instruments, calibration and analytical reliability.

Bioinformatics validation: Examination of algorithms, software tools and computational methods.

Data integrity: Verification of accurate recording, processing and storage of genomic information.

Quality assurance: Assessment of quality-control procedures and laboratory performance.

Data protection: Examination of safeguards protecting identifiable genetic information.

Reporting standards: Verification that genomic findings are accurately interpreted and communicated.

External audits are particularly important where sequencing results are used for clinical diagnosis, genetic screening, forensic investigations or large-scale genomic research.

Legal and regulatory framework in India

1. National Accreditation Board for Testing and Calibration Laboratories (NABL)

NABL provides accreditation services to testing and calibration laboratories in India. Its accreditation framework is based on internationally recognised standards, particularly ISO/IEC 17025 for testing laboratories and ISO 15189 for medical laboratories.

These standards establish requirements concerning technical competence, personnel qualifications, equipment, quality management, testing procedures and reliable reporting.

External assessments under accreditation programmes help verify whether laboratories maintain appropriate scientific and operational standards.

2. Medical Devices Rules, 2017

The Medical Devices Rules, 2017 regulate medical devices in India, including applicable in-vitro diagnostic medical devices.

Where sequencing systems or associated diagnostic products fall within the regulated medical-device framework, manufacturers and relevant stakeholders must comply with applicable licensing, quality and safety requirements.

External assessments may help verify compliance with manufacturing and quality-management obligations.

3. Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023 establishes a framework for processing digital personal data in India.

Genomic sequencing information may constitute personal data where it relates to an identifiable individual. Organisations processing such information must comply with applicable requirements concerning lawful processing, security safeguards and other statutory obligations.

External audits can help organisations evaluate their data-management systems and identify privacy-related weaknesses.

4. Information Technology Act, 2000

The Information Technology Act, 2000 provides a legal framework for electronic records, cybersecurity and certain forms of unauthorised access or disclosure.

Section 43 addresses specified unauthorised acts involving computer systems, while Section 66 deals with computer-related offences involving dishonest or fraudulent conduct.

Section 72 addresses breach of confidentiality and privacy in circumstances covered by that provision.

These provisions may become relevant where genomic sequencing databases or laboratory information systems are improperly accessed or manipulated.

5. Clinical Establishments (Registration and Regulation) Act, 2010

The Clinical Establishments Act, 2010 establishes registration and regulatory requirements for clinical establishments in states and union territories where it applies.

Laboratories covered by the legislation must comply with applicable standards and requirements. External assessments may contribute to institutional quality assurance and accountability.

Major components of external audits

1. Technical validation of sequencing processes

Auditors examine whether sequencing instruments, reagents, sample preparation procedures and analytical methods produce reliable results.

They may assess sequencing accuracy, reproducibility, contamination controls and the handling of low-quality samples.

2. Bioinformatics pipeline assessment

Bioinformatics pipelines convert raw sequencing information into scientifically meaningful results. External auditors examine software versions, reference genome databases, computational algorithms and variant-calling procedures.

They also assess whether pipeline modifications are properly documented and validated before implementation.

3. Data security and privacy assessment

Genomic information contains highly sensitive personal information. Auditors examine access controls, encryption, data retention policies, backup arrangements and information-sharing procedures.

They also evaluate whether laboratories have adequate safeguards against unauthorised access and disclosure.

4. Quality management and documentation

External auditors verify whether laboratories maintain standard operating procedures, equipment maintenance records, personnel training documents, validation reports and corrective-action records.

Proper documentation makes sequencing results traceable and supports scientific reproducibility.

5. Independent performance evaluation

Auditors may examine proficiency-testing results, inter-laboratory comparisons and quality-control reports to determine whether sequencing results remain consistent with accepted scientific standards.

Importance of external audits

External audits offer several important advantages for biotechnology laboratories and healthcare institutions.

First, they improve scientific reliability by identifying technical errors and weaknesses in sequencing procedures.

Second, they strengthen patient protection because inaccurate genomic findings may lead to inappropriate clinical decisions.

Third, they promote regulatory compliance by identifying failures in laboratory documentation, data protection and quality management.

Fourth, independent assessments improve public confidence in genomic research and personalised medicine.

Finally, external audits encourage accountability among biotechnology companies, diagnostic laboratories, research institutions and software developers.

Important judicial decisions and case laws

Although Indian courts have not yet developed a substantial body of judgments specifically concerning external audits of sequencing pipelines, several important judicial decisions establish principles relevant to laboratory accountability, privacy, scientific reliability and independent scrutiny.

1. Justice K.S. Puttaswamy v. Union of India (2017)

The Supreme Court recognised the right to privacy as a fundamental right under Article 21 of the Constitution.

The judgment established that personal information deserves constitutional protection against unjustified interference.

This decision is particularly relevant to genomic sequencing audits because DNA and genetic information can reveal deeply personal details about individuals and their biological relatives. External auditors must therefore examine whether laboratories maintain appropriate privacy and data-security safeguards.

2. Selvi v. State of Karnataka (2010)

The Supreme Court examined the constitutional validity of involuntary administration of narcoanalysis, polygraph examinations and brain electrical activation profile tests.

The Court emphasised the importance of individual autonomy, personal liberty and protection against compelled testimonial evidence.

This judgment is relevant to genetic sequencing because the collection and use of biological information must respect constitutional safeguards, particularly in forensic and investigative contexts.

3. District Registrar and Collector, Hyderabad v. Canara Bank (2005)

The Supreme Court examined privacy protections concerning access to confidential documents and personal information.

The judgment recognised that privacy interests extend to confidential records and that access to such information must respect applicable legal safeguards.

Its principles are relevant to external sequencing audits because auditors may need access to confidential genomic records and laboratory databases. Such access should be limited to legitimate auditing purposes and appropriate legal authority.

4. Shreya Singhal v. Union of India (2015)

The Supreme Court examined constitutional protections relating to freedom of speech and expression in the context of internet regulation.

The decision also considered aspects of intermediary liability and the legal framework governing online information.

Although it does not directly concern genomic sequencing, it provides relevant constitutional context for digital information governance and the regulation of technology-based activities.

5. Samira Kohli v. Dr. Prabha Manchanda (2008)

The Supreme Court examined the principles of informed consent and medical responsibility.

The Court emphasised that valid consent must be based on adequate information and that medical procedures should remain within the scope of consent, except in recognised circumstances.

This decision is relevant to sequencing laboratories because patients should receive appropriate information about genetic testing, its purpose, limitations and relevant uses of their biological samples.

Challenges in conducting external audits

External audits of sequencing pipelines face several technical and legal challenges.

1. Rapid technological development: Sequencing technologies and bioinformatics software change frequently, making continuous validation necessary.

2. Algorithmic transparency: Some commercial sequencing platforms use proprietary algorithms, limiting auditors' ability to examine their complete technical functioning.

3. Genetic data confidentiality: Auditors must balance the need for meaningful inspection with the protection of sensitive personal information.

4. Standardisation difficulties: Different laboratories may use different sequencing platforms, reference databases and analytical methods, making direct comparisons difficult.

5. High auditing costs: Independent technical audits require specialised expertise, advanced infrastructure and significant financial resources.

6. Cross-border data transfers: International genomic research collaborations create additional difficulties concerning jurisdiction, data security and regulatory compliance.

Conclusion

External audits of sequencing pipelines are essential for ensuring the scientific reliability, legal compliance and ethical integrity of modern genomic technologies. They provide independent verification of laboratory procedures, sequencing accuracy, bioinformatics systems, data protection measures and quality-management practices.

In India, these audits are supported by relevant regulatory frameworks, including the Digital Personal Data Protection Act, 2023, the Information Technology Act, 2000, applicable medical-device regulations and recognised laboratory accreditation standards.

Judicial decisions such as Justice K.S. Puttaswamy v. Union of India and Selvi v. State of Karnataka establish important principles concerning privacy, individual autonomy and the responsible use of biological information.

Ultimately, a strong external auditing framework can improve public confidence in genomic research, protect patients' genetic information and ensure that sequencing technologies are developed and used responsibly.